Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

McKesson Corporation (MCK): Finding Strength in Healthcare Supplies

Page 1 of 2

Are you one of the many investors looking to take advantage of the rising demand for healthcare in this country?

Over the coming decade, the healthcare industry is primed to benefit greatly from a series of macroeconomic tailwinds. As a result of healthcare legislation, it is expected we will see 30 million more people in this country receive access to healthcare, thus, it is expected that healthcare demand will increase dramatically. Additionally, the baby boomer population isn’t getting any younger, and it’s expected that by 2020, we will have a 30% increase in the number of citizens over the age of 65.

Now, if you are looking for some safer exposure to the healthcare sector, I may have found a few great options in the medical supplies industry. While supplies may not be as alluring as biotech, the industry stands in a equally attractive position to take advantage of healthcare demand. In this article, I would like to highlight a few names to consider for your longer-term investment portfolio.

McKesson Corporation (NYSE:MCK)

Up first, McKesson Corporation (NYSE:MCK), a diversified healthcare company positioned well for broad growth. In a recent trip to the hospital, I was very impressed with the quantity of McKesson products used throughout a variety of different procedures. Everything from basic medical supplies to complex surgical offerings, the company delivers a comprehensive portfolio of health care products, technology, equipment, and related services across the country.

McKesson Corporation (NYSE:MCK) is currently the largest pharmaceutical distributor in North America with over 40,000 distribution points. What caught my eye when researching this company was the potentially lucrative medical technologies business. With greater healthcare demand, coupled with staff shortages, the healthcare industry is likely to see a rise in demand for automated offerings to ease the strain.

McKesson Corporation (NYSE:MCK) automates the health care delivery processes with a wide variety of clinical, financial, and administrative software applications. With the drastic shortage of nurses is expected to rise, the company’s nursing automation solutions should be in particular demand. These solutions offer hospitals faster processing times and reduced patient care times for nursing staff, thus saving healthcare provides significant costs.

Next up, Medtronic, Inc. (NYSE:MDT), the world’s largest medical device maker. The company offers investors broad exposure across a range of medical device industries including endovascular, neuromodulation, surgical technologies, and diabetes. Medtronic has positioned itself as an industry leader in the diabetes space with its proprietary integrated diabetes management system.

The company’s system combines world class glucose monitoring technology with rapid acting insulin pumps to offer patients rapid treatment, greatly enhancing patient safety. Medtronic, Inc. (NYSE:MDT) is the only manufacturer to offer this product combination which sets the company up well to gain market share in the future.

Last up, Henry Schein, Inc. (NASDAQ:HSIC), a more diversified global supplier of medical, dental, and animal health supplies. This company has been around for over 80 years and in this time, it has developed a reputation for offering the highest in quality supplies. As of today, the company has a large footprint to say the least with over 100,000 products reaching almost 775,000 customers across the globe.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!